106 related articles for article (PubMed ID: 33813381)
1. The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
Ogo A; Miyake S; Kubota H; Higashida M; Matsumoto H; Teramoto F; Hirai T; Ueno T
Anticancer Res; 2021 Apr; 41(4):1771-1778. PubMed ID: 33813381
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic acid modifies cytokine activity and inhibits cell proliferation in an oesophageal cancer cell line.
Kubota H; Matsumoto H; Higashida M; Murakami H; Nakashima H; Oka Y; Okumura H; Yamamura M; Nakamura M; Hirai T
Anticancer Res; 2013 Oct; 33(10):4319-24. PubMed ID: 24122998
[TBL] [Abstract][Full Text] [Related]
3. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
[TBL] [Abstract][Full Text] [Related]
4. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
[TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway.
Takizawa K; Kamijo R; Ito D; Hatori M; Sumitani K; Nagumo M
Br J Cancer; 1999 Jun; 80(7):954-63. PubMed ID: 10362102
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 Polyunsaturated Fatty Acids Enhance Cisplatin Efficacy in Gastric Cancer Cells by Inducing Apoptosis via ADORA1.
Sheng H; Chen X; Liu B; Li P; Cao W
Anticancer Agents Med Chem; 2016; 16(9):1085-92. PubMed ID: 27025656
[TBL] [Abstract][Full Text] [Related]
7. α-Hederin Arrests Cell Cycle at G2/M Checkpoint and Promotes Mitochondrial Apoptosis by Blocking Nuclear Factor-κB Signaling in Colon Cancer Cells.
Sun D; Shen W; Zhang F; Fan H; Tan J; Li L; Xu C; Zhang H; Yang Y; Cheng H
Biomed Res Int; 2018; 2018():2548378. PubMed ID: 30363706
[TBL] [Abstract][Full Text] [Related]
8. Polyunsaturated fatty acids potentiate cytotoxicity of cisplatin in A549 cells.
Zajdel A; Wilczok A; Latocha M; Tarkowski M; Kokocińska M; Dzierzewicz Z
Acta Pol Pharm; 2014; 71(6):1060-5. PubMed ID: 25745780
[TBL] [Abstract][Full Text] [Related]
9. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
Chen C; Ai QD; Wei YH
J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990
[TBL] [Abstract][Full Text] [Related]
10. Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
Ho JN; Byun SS; Lee SE; Youn JI; Lee S
Oncol Rep; 2019 Apr; 41(4):2482-2490. PubMed ID: 30816494
[TBL] [Abstract][Full Text] [Related]
11. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.
Ui T; Morishima K; Saito S; Sakuma Y; Fujii H; Hosoya Y; Ishikawa S; Aburatani H; Fukayama M; Niki T; Yasuda Y
Oncol Rep; 2014 Feb; 31(2):619-24. PubMed ID: 24317439
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells.
Ong PS; Wang XQ; Lin HS; Chan SY; Ho PC
Int J Oncol; 2012 May; 40(5):1705-13. PubMed ID: 22328352
[TBL] [Abstract][Full Text] [Related]
13. Viability inhibition effect of gambogic acid combined with cisplatin on osteosarcoma cells via mitochondria-independent apoptotic pathway.
Zhao W; You CC; Zhuang JP; Zu JN; Chi ZY; Xu GP; Yan JL
Mol Cell Biochem; 2013 Oct; 382(1-2):243-52. PubMed ID: 23812885
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic acid induced SKOV-3 cell apoptosis through ERK1/2-mTOR-NF-κB pathways.
Han L; Zhang Y; Meng M; Cheng D; Wang C
Anticancer Drugs; 2016 Aug; 27(7):635-42. PubMed ID: 27176035
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells.
Ren K; Zhang W; Wu G; Ren J; Lu H; Li Z; Han X
Biomed Pharmacother; 2016 Dec; 84():1748-1759. PubMed ID: 27876206
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin in combination with bergamottin potentiates TNF-induced apoptosis through modulation of NF-κB signalling pathway in human chronic myelogenous leukaemia.
Kim SM; Lee EJ; Lee JH; Yang WM; Nam D; Lee JH; Lee SG; Um JY; Shim BS; Ahn KS
Pharm Biol; 2016 Oct; 54(10):2050-60. PubMed ID: 26911804
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells.
Chen HM; Lai ZQ; Liao HJ; Xie JH; Xian YF; Chen YL; Ip SP; Lin ZX; Su ZR
Int J Mol Med; 2018 Mar; 41(3):1447-1454. PubMed ID: 29328398
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.
Horibe S; Matsuda A; Tanahashi T; Inoue J; Kawauchi S; Mizuno S; Ueno M; Takahashi K; Maeda Y; Maegouchi T; Murakami Y; Yumoto R; Nagai J; Takano M
Life Sci; 2015 Mar; 124():31-40. PubMed ID: 25625243
[TBL] [Abstract][Full Text] [Related]
19. Lapatinib, a dual inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2, potentiates the antitumor effects of cisplatin on esophageal carcinoma.
Guo XF; Zhu XF; Zhong GS; Deng BG
Dis Esophagus; 2013 Jul; 26(5):487-95. PubMed ID: 22458639
[TBL] [Abstract][Full Text] [Related]
20. Tannic acid synergistically enhances the anticancer efficacy of cisplatin on liver cancer cells through mitochondria‑mediated apoptosis.
Geng N; Zheng X; Wu M; Yang L; Li X; Chen J
Oncol Rep; 2019 Nov; 42(5):2108-2116. PubMed ID: 31432178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
